User contributions for Lazy
From Glioblastoma Treatments
Jump to navigationJump to search
29 March 2024
- 23:2823:28, 29 March 2024 diff hist +446 Main Page →Radiation via Monoclonal Antibodies
- 21:5721:57, 29 March 2024 diff hist +636 Main Page →Proton radiation therapy
- 21:5621:56, 29 March 2024 diff hist +503 Main Page No edit summary
- 21:5221:52, 29 March 2024 diff hist +79 Gamma Knife Radiosurgery No edit summary current
- 21:5121:51, 29 March 2024 diff hist +1,721 N Gamma Knife Radiosurgery Created page with "{{TreatmentInfo |drug_name=Gamma Knife Radiosurgery (GKRS) for GBM |FDA_approval=Yes |used_for=Newly diagnosed Glioblastoma Multiforme (GBM) |clinical_trial_phase=N/A (Established treatment modality) |common_side_effects=Lower compared to traditional GBM treatments, with no significant radiation-induced toxicities reported in recent studies. |OS_without=14-16 months with standard treatment. |OS_with=Comparable to standard treatment, specifics depend on individual patient..."
- 21:3721:37, 29 March 2024 diff hist −464 Radiation via Monoclonal Antibodies No edit summary
- 21:3521:35, 29 March 2024 diff hist +2,677 N Radiation via Monoclonal Antibodies Created page with "<includeonly> {| class="wikitable" |- ! Property !! Information |- | Drug Name || Radiation via Monoclonal Antibodies |- | FDA Approval || Under research, not yet FDA-approved for general use |- | Used for || Glioblastoma (GBM) and potentially other high-grade glioma tumors |- | Clinical Trial Phase || Various phases, with some treatments in early clinical trials |- | Common Side Effects || Side effects vary depending on the specific monoclonal antibody and radioactive c..."
- 17:4117:41, 29 March 2024 diff hist 0 Main Page →Proton radiation therapy
- 17:4017:40, 29 March 2024 diff hist −130 Main Page →Proton radiation therapy
- 17:2817:28, 29 March 2024 diff hist 0 Main Page →Proton radiation therapy
- 17:2417:24, 29 March 2024 diff hist 0 Main Page →Proton radiation therapy
- 17:2317:23, 29 March 2024 diff hist 0 Main Page →Proton radiation therapy
- 17:2217:22, 29 March 2024 diff hist 0 Main Page →Proton radiation therapy
- 17:2117:21, 29 March 2024 diff hist −34 Main Page →Proton radiation therapy
- 11:2811:28, 29 March 2024 diff hist +20 Template:PropertyTableFormat No edit summary
- 09:4409:44, 29 March 2024 diff hist −2 Template:PropertyTableFormat No edit summary
- 09:1709:17, 29 March 2024 diff hist +4 Template:PropertyTableFormat No edit summary
- 09:1709:17, 29 March 2024 diff hist +12 Template:PropertyTableFormat No edit summary
- 09:1409:14, 29 March 2024 diff hist +72 Main Page →Proton radiation therapy
- 09:1409:14, 29 March 2024 diff hist +302 N Template:PropertyTableFormat Created page with "{| class="wikitable" ! Property ! Value |- | Drug Name | {{{Has drug name}}} |- | FDA Approval | {{{Has FDA approval}}} |- | Used For | {{{Used for}}} |- | Clinical Trial Phase | {{{Clinical trial phase}}} |- ... | Toxicity Explanation | {{{Toxicity explanation}}} |- | Description | {{{Book text}}} |}"
- 09:1009:10, 29 March 2024 diff hist +4 Main Page →Proton radiation therapy
- 09:0909:09, 29 March 2024 diff hist −34 Main Page →Proton radiation therapy
- 09:0809:08, 29 March 2024 diff hist +8 Main Page →Proton radiation therapy
- 09:0709:07, 29 March 2024 diff hist 0 Main Page →Proton radiation therapy
- 09:0609:06, 29 March 2024 diff hist +5 Main Page →Proton radiation therapy
- 09:0509:05, 29 March 2024 diff hist +558 Main Page No edit summary
- 09:0009:00, 29 March 2024 diff hist −237 Proton Radiation Therapy No edit summary current
- 08:5908:59, 29 March 2024 diff hist +1,877 N Proton Radiation Therapy Created page with "{{TreatmentInfo |drug_name=Proton Beam Therapy (PBT) |FDA_approval=Yes |used_for=Glioblastoma and other cancers |clinical_trial_phase=Ongoing research and clinical trials |common_side_effects=Radiation dermatitis, temporary alopecia, radiation otitis, radiation necrosis (more prevalent in PBT group) |OS_without=Data varies; traditional radiation therapies offer median OS of around 16-21 months for glioblastoma |OS_with=High-dose PBT showed a median OS of 65.6 months for..."
- 08:5008:50, 29 March 2024 diff hist +10,757 Main Page No edit summary
- 06:1006:10, 29 March 2024 diff hist 0 Main Page →Optune (formerly NovoTTF-100A) by Novocure
- 06:1006:10, 29 March 2024 diff hist +106 Optune No edit summary current
- 06:0906:09, 29 March 2024 diff hist +274 Main Page →Optune (formerly NovoTTF-100A) by Novocure
- 06:0506:05, 29 March 2024 diff hist +1,824 N Optune Created page with "{{TreatmentInfo |drug_name=Optune (Optune Gio® for newer version) |FDA_approval=Approved for newly diagnosed glioblastoma in October 2015; ongoing trials for broader applications |used_for=Newly diagnosed glioblastoma, with trials for other cancers ongoing |clinical_trial_phase=Phase 3 (EF-14 Trial); Phase 3 TRIDENT trial ongoing |common_side_effects=Mild to moderate skin irritation beneath transducer arrays, thrombocytopenia, nausea, constipation, vomiting, fatigue, he..."
- 05:5705:57, 29 March 2024 diff hist +4 Main Page No edit summary
- 05:5705:57, 29 March 2024 diff hist +2 Main Page No edit summary
- 05:5505:55, 29 March 2024 diff hist +30 Main Page No edit summary
- 05:5405:54, 29 March 2024 diff hist +44 Main Page No edit summary
- 05:4705:47, 29 March 2024 diff hist −6 Main Page No edit summary
- 05:4505:45, 29 March 2024 diff hist +1,159 Category:Nutraceuticals →Nutraceuticals and Herbals
- 05:4505:45, 29 March 2024 diff hist −24 CBD No edit summary
- 05:4305:43, 29 March 2024 diff hist +1,431 Main Page →Nutraceuticals and Herbals
- 05:4005:40, 29 March 2024 diff hist +240 Main Page →Hormones
- 05:3905:39, 29 March 2024 diff hist +734 Main Page →Repurposed Drugs
- 05:3705:37, 29 March 2024 diff hist +1,198 Main Page →Over-the-Counter Drugs and Supplements
- 05:3605:36, 29 March 2024 diff hist +234 Main Page No edit summary
- 05:3405:34, 29 March 2024 diff hist +1,491 N Category:Over-the-Counter Drugs and Supplements Created page with "The treatments discussed above generally require a physician’s cooperation in prescribing them. However, there are a number of agents available over-the-counter that have promising anti-cancer properties, and it is reasonable to believe that these can increase the chances of surviving. Some of these with supporting clinical evidence (e.g., protonpump inhibitors such as Prilosec) have been discussed above. A frequent conflict between patients and their oncologists is th..." current
- 05:3105:31, 29 March 2024 diff hist −7 Main Page →Combining the Standard Treatment with Additional Agents
- 05:2905:29, 29 March 2024 diff hist +20,457 Main Page No edit summary
- 00:4800:48, 29 March 2024 diff hist +11,296 Main Page No edit summary Tag: Visual edit: Switched
28 March 2024
- 11:0011:00, 28 March 2024 diff hist −12 Main Page →Treatment Categories